Vertex Pharmaceuticals (VRTX) Gross Profit Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.11% |
| Dec 31, 2025 | 13.84% |
| Sep 30, 2025 | 14.51% |
| Jun 30, 2025 | 13.80% |
| Mar 31, 2025 | 12.22% |
| Dec 31, 2024 | 144.40% |
| Sep 30, 2024 | 23.81% |
| Jun 30, 2024 | 23.06% |
| Mar 31, 2024 | 25.20% |
| Dec 31, 2023 | 23.51% |
| Sep 30, 2023 | 26.31% |
| Jun 30, 2023 | 27.52% |
| Mar 31, 2023 | 29.93% |
| Dec 31, 2022 | 28.90% |
| Sep 30, 2022 | 32.26% |
| Jun 30, 2022 | 32.54% |
| Mar 31, 2022 | 22.63% |
| Dec 31, 2021 | 35.54% |
| Sep 30, 2021 | 37.43% |
| Jun 30, 2021 | 32.63% |
| Mar 31, 2021 | 34.48% |
| Dec 31, 2020 | 32.84% |
| Sep 30, 2020 | 37.79% |
| Jun 30, 2020 | 54.82% |
| Mar 31, 2020 | 61.93% |
| Dec 31, 2019 | -17.28% |
| Sep 30, 2019 | 45.16% |
| Jun 30, 2019 | 48.20% |
| Mar 31, 2019 | 47.35% |
| Dec 31, 2018 | 45.28% |
| Sep 30, 2018 | 27.27% |
| Jun 30, 2018 | 23.00% |
| Mar 31, 2018 | 13.86% |
| Dec 31, 2017 | 17.04% |
| Sep 30, 2017 | 10.60% |
| Jun 30, 2017 | 8.55% |
| Mar 31, 2017 | 13.83% |
| Dec 31, 2016 | -5.88% |
| Sep 30, 2016 | -1.49% |